How does NXTG's PB Ratio compare to its peers?

Insufficient data to calculate NXTG's Price-To-Book Ratio vs. peers for valuation analysis.

How does NXTG's PB Ratio compare vs other companies in the Asian Biotechs Industry?

Insufficient data to calculate NXTG's Price-To-Book Ratio vs. industry for valuation analysis.

What is NXTG's PB Ratio compared to its Fair PB Ratio? This is the expected PB Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

Insufficient data to calculate NXTG's Price-To-Book Fair Ratio for valuation analysis.

What is the Fair Price of NXTG when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Insufficient data to calculate NXTG's fair value for valuation analysis.

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Insufficient data to show price forecast.

Nextage Therapeutics TASE:NXTG Stock Report

Last Price

₪0.77

Market Cap

₪26.0m

7D

7.7%

1Y

143.1%

Updated

22 Dec, 2024

Data

Company Financials

Nextage Therapeutics Ltd

TASE:NXTG Stock Report

Market Cap: ₪26.0m

NXTG Stock Overview

A pharmaceutical company, develops cannabinoid-based products. More details

NXTG fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	0/6
Dividends	0/6

Risk Analysis

Does not have a meaningful market cap (₪26M)

Has not reported any financial data

Highly volatile share price over the past 3 months compared to the IL market

Shareholders have been diluted in the past year

My Notes

Capture your thoughts, links and company narrative

Nextage Therapeutics Ltd Competitors

Can-Fite BioPharma

TASE:CANF

₪36.8m

Clal Biotechnology Industries

TASE:CBI

₪54.9m

XTL Biopharmaceuticals

TASE:XTLB

₪64.0m

Grace Breeding

TASE:GRAC

₪66.0m

Price History & Performance

Summary of share price highs, lows and changes for Nextage Therapeutics
Historical stock prices
Current Share Price	₪0.77
52 Week High	₪0.96
52 Week Low	₪0.28
Beta	0
1 Month Change	-5.50%
3 Month Change	14.69%
1 Year Change	143.08%
3 Year Change	-66.51%
5 Year Change	n/a
Change since IPO	-82.23%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

	NXTG	IL Biotechs	IL Market
7D	7.7%	1.1%	0.5%
1Y	143.1%	-25.0%	23.7%

Return vs Industry: NXTG exceeded the IL Biotechs industry which returned -24.8% over the past year.

Return vs Market: NXTG exceeded the IL Market which returned 23% over the past year.

Price Volatility

Is NXTG's price volatile compared to industry and market?
NXTG volatility
NXTG Average Weekly Movement	9.2%
Biotechs Industry Average Movement	5.0%
Market Average Movement	4.2%
10% most volatile stocks in IL Market	8.0%
10% least volatile stocks in IL Market	3.0%

Stable Share Price: NXTG's share price has been volatile over the past 3 months compared to the IL market.

Volatility Over Time: NXTG's weekly volatility has decreased from 17% to 9% over the past year, but is still higher than 75% of IL stocks.

About the Company

Founded	Employees	CEO	Website
1982	n/a	Abraham Dreazen	www.nxtg.co.il

Nextage Therapeutics Ltd, a pharmaceutical company, develops cannabinoid-based products. The company was formerly known as Nextage Cannabis Innovation Ltd. and changed its name to Nextage Therapeutics Ltd in August 2020.

Nextage Therapeutics Ltd Fundamentals Summary

How do Nextage Therapeutics's earnings and revenue compare to its market cap?
NXTG fundamental statistics
Market cap	₪26.05m
Earnings (TTM)	₪0
Revenue (TTM)	n/a

n/a

P/E Ratio

n/a

P/S Ratio

Is NXTG overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
NXTG income statement (TTM)
Revenue	₪0
Cost of Revenue	₪0
Gross Profit	₪0
Other Expenses	₪0
Earnings	₪0

Last Reported Earnings

n/a

Next Earnings Date

n/a

Earnings per share (EPS)	0
Gross Margin	0.00%
Net Profit Margin	0.00%
Debt/Equity Ratio	0.0%

How did NXTG perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/22 07:33
End of Day Share Price	2024/12/19 00:00
Earnings	N/A
Annual Earnings	N/A

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Nextage Therapeutics Ltd is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution